10th Annual Meeting DIA Japan 2013

How will medical products be developed in the future in an increasingly globalized world? Drug developments from the bridging strategy to global clinical trials have been changed and the variations of development are also increasing, it has been important business strategy how a company get a marketing authorization for pharmaceuticals in global strategy. In addition, the proportion of targeting strategy, which it is a world-class new trend drug therapy with companion diagnostics, antibody and orphan drugs etc., is greater. When we turn our eyes to the domestic situation, it is existed unique Japanese issue that expensive medicines are increasingly tight in the budget, including medical insurance. Under these circumstances, regulators and heads of R&D department will exchange their opinions about the future drug development, including how to develop drug in the future and how a way of thinking of Regulatory authorities change in the future etc.